Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is
an area of active research. This article is aimed to give an update on recent advances in all …

Cancer and heart failure (HF) are common medical conditions with a steadily rising
prevalence in industrialized countries, particularly in the elderly, and they both potentially …

Aim To assess adverse outcomes attributable to non‐cardiac co‐morbidities and to compare
their effects by left ventricular ejection fraction (LVEF) group [LVEF< 50%(heart failure with …

Aims We sought to determine whether atrioventricular junction ablation (AVJA) in patients
with cardiac resynchronization therapy (CRT) implantable cardioverter‐defibrillator (ICD) …

Objectives The study sought to assess the prognostic impact of type 2 diabetes in patients
presenting with ventricular tachyarrhythmias on admission. Background Data regarding the …

Abstract Background The prospective WEARIT-II-EUROPE registry aimed to assess the
value of the wearable cardioverter-defibrillator (WCD) prior to potential ICD implantation in …

Aim There is limited information on the outcomes after primary prevention implantable
cardioverter‐defibrillator (ICD) implantation in patients with heart failure (HF) and diabetes …

Aims The aim of this study is to quantify healthcare resource utilization among non-
responders to cardiac resynchronization therapy (CRT-NR) by heart failure (HF) events and …

Aims There is a paucity of studies investigating a dose-dependent association between beta-
blocker therapy and risk of outcome. In a nationwide cohort of primary prevention …

Background Primary prophylactic implantable cardioverter-defibrillators (ICDs) in patients
with non-ischaemic cardiomyopathy (NICMP) remains controversial. This study sought to …